Document Mentions (3 shared documents)

EFTA00136939

3 mentions1 same-page

Page ?Same page

s continue to spike, Mayor Lori Lightfoot followed through Thursday by imposing a 10 p.m. curfew on all nonessential city businesses." In addition, Lightfoot said the city "will again prohibit indoor service at traditional taverns and EFTA00136972 brewery taprooms without food licenses, and asked reside

e, Petrella, 2.65M) reports that "days after threatening to roll back restrictions on Chicago businesses if COVID-19 cases continue to spike, Mayor Lori Lightfoot followed through Thursday by imposing a 10 p.m. curfew on all nonessential city businesses." In addition, Lightfoot said the city "will again prohib

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a

EFTA00135796

2 mentions1 same-page

Page ?Same page

s continue to spike, Mayor Lori Lightfoot followed through Thursday by imposing a 10 p.m. curfew on all nonessential city businesses." In addition, Lightfoot said the city "will again prohibit indoor service at traditional taverns and brewery taprooms without food licenses, and asked residents to cap any

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

EFTA00148445

2 mentions1 same-page

Page ?Same page

s continue to spike, Mayor Lori Lightfoot followed through Thursday by imposing a 10 p.m. curfew on all nonessential city businesses." In addition, Lightfoot said the city "will again prohibit indoor service at traditional taverns and brewery taprooms without food licenses, and asked residents to cap any

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust